<< Prev  18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 Next >>

Will Other Companies Seek OxyContin-like Generics Safety Ban? [502 Words] 04/25/2013

Panel to Discuss SpinalMotion PMAs for Disc Replacement [200 Words] 04/25/2013

Assay Migration Study Guidance Out [160 Words] 04/24/2013

‘Amazing’ Response to ‘Breakthrough’ Designations: Woodcock [954 Words] 04/24/2013

Hamburg ‘Enormously Troubled’ by FDA’s Fiscal Plight [726 Words] 04/24/2013

Device Problem Reporting — There’s an App for That [152 Words] 04/24/2013

Guidance on Safety Considerations for Container Labeling [101 Words] 04/24/2013

Recent Court Decisions Open Door to More State Liability Suits: WLF [340 Words] 04/24/2013

Merck Gains ‘Breakthrough’ Status for Melanoma Therapy [140 Words] 04/24/2013

Law and Public Policy vs. Device Technology at FDLI [995 Words] 04/24/2013

<< Prev  18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37  Next >>